Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Pitolisant Hydrochloride Tablets

Approved

化学药品

Pitolisant Hydrochloride Tablets

Bioprojet Pharma🇨🇳 National Medical Products Administration

Approval Date: Jun 30, 2023
Approval ID: 8TELh88pmPX
Company: Bioprojet Pharma
Type: 化学药品

Approval Details

Approval Id: 8TELh88pmPX
Approval Number: 国药准字HJ20230087
Generic Name: 盐酸替洛利生片
Generic Name En: Pitolisant Hydrochloride Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 4.5mg（按C₁₇H₂₆ClNO计）
Reg Date: 2023-06-30
Expired Date: 2028-06-29
Company Name: Bioprojet Pharma
Production Company Name: PATHEON PHARMACEUTICALS INC.
Company Detail Path: /organization/bioprojet-pharma
Production Company Detail Path: /organization/patheon-pharmaceuticals-inc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 30, 2023

Approval ID

8TELh88pmPX

Type

化学药品

Back to NMPA Approvals

盐酸替洛利生片 - NMPA Drug Approval Details